Clinical Trials Browser

Phase 1/2 × Advanced Malignant Tumors × 30 days × Clear all

NCT05229497 2026-03-09

A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors

Phase 1/2 Active not recruiting

Advanced Malignant Tumors

NCT05214482 2026-03-03

A Study of AK112 in Advanced Malignant Tumors

Phase 1/2 Completed

Advanced Malignant Tumors